POSTER SESSIONS ABSTRACTS
Poster Session XIII
P-13
PHARMACOVIGILANCE, PHARMACOEPIDEMIOLOGY
| P-13/1 | The presence of two specific SNP
may reduce mesalazine efficacy. Future prospects for
the clinical management of IBD patients V. Perrone, E. Moroni, P. Danelli, C. Perrotta, C. Carnovale, R. Colognato, G. Milani, E. Clementi, S. Radice, S. Antoniazzi (Milano) |
| P-13/2 | Intensive monitoring program of
adverse drug reactions inemergency department (MEREAFaPS study): the Tuscan
experience. A. Pergola, C. Blandizzi, M. Rossi, A. Capogrosso Sansone, M. Moschini, F. Rimoli, E. Cecchi, A. Vannacci, S. Montagnani, C. Scollo, E. Ruggiero, S. Mantarro, L. Picchianti, M.C. Leo, G. Giustarini, T. Testi, M. Santini, L. Spisni, F. Mannelli, M.S. Verzuri, M. Tuccori ( Pisa, Siena, Firenze, Prato) |
| P-13/3 | Lens care products efficacy and
tolerance, a difficult balance. A review of literature data V. Ghirardi, A. Nunziata (Pomezia , Pomezia) |
| P-13/4 | A case of haemorrhagic cystitis
and conjunctivitis by inhaled albuterol and beclomethasone C. Carnovale, A. Piazza, S. Antoniazzi, V. Perrone, E. Clementi , S. Radice (Milano, Monza) |
| P-13/5 | Impact of notoriety bias on
reporting of pancreatitis with antidiabetics: the case of exenatide E. Raschi, C. Piccinni, E. Poluzzi, F. De Ponti ( |
| P-13/6 | Combined
treatment of Phenobarbital and Lamotrigine induced blood dyscrasia in an
epileptic patient L. Gallelli, A. Siniscalchi , G.A. Tolotta, C. Palleria, C. Giofrè, G. De Sarro (Catanzaro, Cosenza) |
| P-13/7 | Prescription of potential drug-drug interaction in two Italian
Regions E. Tragni, M. Casula, V. Pieri, G. Favato, A. Marcobelli, M.G. Trotta, A.L. Catapano (Milano, Ancona, Potenza) |
| P-13/8 | Adverse reactions related to
systemic antibiotics: data from the French national pharmacovigilance
database. F. Salvo, F. Haramburu , C. Dumartin , A. Pariente, A. Fourrier-Réglat , P. Auriche , G. Miremont-Salamé (Bordeaux, Paris) |
| P-13/9 | Psychiatric
disorders associated with tyrosin-kinase inhibitors: a signal detection
analysis of the Italian spontaneous reporting database of adverse drug reactions S. Montagnani, M. Tuccori , C. Scollo, S. Mantarro, G. Giustarini, C. Blandizzi (Pisa) |
| P-13/10 | Skin cancers associated with
anti-TNF-α drugs: a disproportional analysis
of the Italian spontaneous reporting database of adverse drug reactions. S. Mantarro, M. Tuccori, C. Scollo, S. Montagnani, G. Giustarini, M. Moschini, F. Lapi, A. Testi, E. Ruggiero, A. Vannacci, L. Sottosanti, A. Mugelli, F. Ferrazin, C. Blandizzi (Pisa, Firenze, Roma) |
| P-13/11 | Alopecia effluvium following administration of bivalent vaccine
as prophylaxis against human papilloma virus: two case reports C. Scollo, M. Tuccori, C. Pisani, G. Giustarini, S. Montagnani, S. Mantarro, C. Cirinei, F. Lena, M. Rubinelli, M. Pardini, L. Bachini, C. Blandizzi (Pisa, Livorno, Grosseto) |
| P-13/12 | Oral anticancer
drug and patient safety F. Musicco , M.G. Celeste, A. Tufo, C. Peschi , R. Fraschetti , N. Mores (Roma) |
| P-13/13 | Findings of osteonecrosis of the
jaw under combined bisphosphonate and antiangiogenic therapies: an emergent
problem? I. Morreale, A. Alaimo, O. Di Fede, A. Musciotto, V. Fusco, N. D'Alessandro, G. Campisi (Palermo, Alessandria) |
| P-13/14 | Adverse events and interactions
due to Chinese Herbal Drugs in Italy. A three-year pharmacoepidemiology,
pharmacogenomic and pharmacovigilance survey. A. Vannacci, F. Lapi, E. Gallo, A. Pugi, E. Lucenteforte, R. Bonaiuti, V. Mascherini, R. Raschetti, F. Menniti-Ippolito, A. Mugelli, F. Firenzuoli (Firenze, Roma) |
| P-13/15 | Italian
post-marketing surveillance for adverse event reports after MF59-adjuvanted
H1N1v vaccination E. Parretta, B. Ianniello, F. Ferrazin, F. Rossi, A. Capuano (Napoli, Roma) |
| P-13/16 | Prescribing pattern and adherence to the statins therapy: a
population-based study in Italian primary health care L. Sportiello, A. Capuano, C. Ferrajolo, C. Pagliaro, I. Lombardi, C. Sirianni, R. Ferrara , M. Tari, A.P. Caputi, F. Rossi, V. Arcoraci (Napoli, Rotterdam, Caserta, Messina) |
| P-13/17 | Observational study comparing the safety of typical and atypical
antipsychotic drugs in patients affected by dementia with Behavioural and Psychological
Symptoms of Dementia (BPSD) M.G. Sullo, R. Formica, S. Potenza, I. Putaturo, R. Cusano, T. Pisapia, S. Ruggiero, B. Rinaldi, A. Capuano, F. Rossi (Napoli, Roma) |
| P-13/18 | Analysis of toxic exposures to
cosmetic products through the data base of the Poison Control Centre of the
Niguarda Ca’ Granda Hospital S. Ruggiero, P.A. Moro, F. Davanzo , L. Sportiello, A. Capuano, R. Rossi, L. Sautebin (Napoli, Milano) |
| P-13/19 | Inadequate
cancer pain management in clinical trials V. Maggini, E. Lucenteforte, R. Maione, V. Fabbroni, C. Tomino, A. Mugelli (Firenze, Roma) |
| P-13/20 | Acute Hepatitis associated with use of green tea and oral
contraceptives: a case report E. Gallo, A. Pugi, V. Maggini, G. Pieraccini, R. Notaro, L. Longo, V. Annese, G. Vannozzi, F. Firenzuoli, A. Mugelli, A. Vannacci (Firenze) |
| P-13/21 | Post-marketing
drug surveillance of psychotropic drugs: a pilot study in a pediatric setting M.S. Gagliostro, A. Magazù, V. Arcoraci, P.M. Cutroneo, A. Gagliano, E. Germanò, R. Siracusano, G. Masi, E. Spina (Messina, Pisa) |
| P-13/22 | An investigation on the perception
of the risk on the use of medicinal plants commonly used and sold by
herbalists in Tuscany E. Gallo, E. Lucenteforte, S. Harrison, M. Di Pirro, M. Moschini, L. Gori, V. Mascherini, F. Firenzuoli, A. Mugelli, A. Vannacci (Firenze) |
| P-13/23 | Adverse Reactions to Incretin-Based Therapies: Data From The
Italian Spontaneous Reporting System P.M. Cutroneo, L. Sottosanti, A. Russo, P. Cananzi, V. Pizzimenti, D. Crupi, S. Potenza, D. Morlino, F. Ferrazin, A.P. Caputi (Messina, Roma, Palermo) |
| P-13/24 | Potential interactions between
synthetic drugs, herbal medicine and dietary supplements during preoperative
anaesthesiological assessment. E. Gallo, A. Pugi, E. Lucenteforte, G. Diddi, M. |
| P-13/25 | Lack of
standardization in a cod liver oil dietary
supplement: three cases of hypervitaminosis D A. Vannacci, E. Gallo, E. Giocaliere, A. Pugi, F. Menniti-Ippolito, D. Bettoni, F. Capurro, G. Pieraccini, G. Moneti, F. Firenzuoli (Firenze, Roma, Brescia, Novara) |
| P-13/26 | Use of medicinal natural products by Italian women in Sicily A. Pieratti, D. Crupi, G. Calapai, A. De Sarro (Messina) |
| P-13/27 | Intensive monitoring of AdverSe
drug reactions in patients receiving pharmacological Treatments for
Rheumatoid Arthritis and other rheumatologic diseases, with particular focus
on biotechnoLoGicAL drUgS: the ASTRAGALUS study. A preliminary 6-month
analysis G. Giustarini, M. Tuccori, L. Bazzichi, S. Manganelli, F. Peruzzi, O.M. Sacu, L. Picchianti, A. Capogrosso, M. Rossi, F. Sernissi, C. Giacomelli, R. Neri, M.G. De Montis, F. Nacci, F. Lapi, A. Pergola, C. Scollo, S. Mantarro, L. Sabadini, A. Mugelli, S. Bombardieri, M. Matucci-Cerinic, M. Galeazzi, C. Blandizzi (Pisa, Siena, Firenze, Arezzo) |
| P-13/28 | Safety profile
of antiviral analogues: a case/non case study using the Italian spontaneous
reporting database A. Pugi, R. Bonaiuti, M. Tuccori, M. Moschini, V. Maggini, L. Sottosanti, S. Potenza, F. Ferrazin, A. Mugelli, A. Vannacci, F. Lapi (Firenze, Pisa, Roma) |
| P-13/29 | Torsade de
Pointes and QT prolongation with antipsychotics: a disproportionality
analysis in the FDA Adverse Event Reporting System (FDA_AERS) E. Raschi, E. Elisabetta, A. Ariola, F. Fabrizio (Bologna) |
| P-13/30 | Tramadol-associated
Psychiatric Adverse Events: A Signal from the pharmacovigilance data of
Italian Medicines Agency (AIFA) L. Sottosanti, F. Ferrazin, A. Capuano, F. Rossi, S. Potenza (Roma, Napoli) |
| P-13/31 | Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to
Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic
fractures F. Lapi, E. Sessa, M. Di Bari, G. Corrao, A. Zambon, L. Scotti, M. Sturkenboom, P. Geppetti, D. Gregori, F. Carle, A. Menna, AR. Vestri, A. Vaccheri, C. Piccin, A. Puccini, N. Montanaro, V. Arcoraci, AP. Caputi, G. Mazzaglia (Firenze, Milano, Rotterdam, Padova, Ancona, Latina, Bologna, Messina) |
| P-13/32 | Prescription of proton pump
inhibitor during 2006-2009 in Campania region E. Tragni, M. Casula, S. Riegler, CM. Desogus, M. Gentili, S. Cammarota, A. Citarella, E. Menditto, E. Novellino, A.L. Catapano (Milano, Napoli) |
| P-13/33 | Prescription of
anti-osteoporosis drugs during 2004-2006 in an Italian Local Health Unit M. Casula, E. Tragni, A. Filippi, F. Decè , L. Defendi, L. Gandolfi, L. Perego, R. Piccinelli, A.L. Catapano (Milano, Firenze, Bergamo) |
| P-13/34 | Adherence to
anti-osteoporosis therapy in an Italian population M. Casula, E. Tragni, A. Filippi, F. Decè, L. Defendi, L. Gandolfi, L. Perego, R. Piccinelli, A.L. Catapano (Milano, Firenze, Bergamo) |
| P-13/35 | The Safety of NSAIDs (SOS)
project: what can be learned from quantitative reviews of RCTs. F. Salvo, A. Fourrier-Réglat, F. Bazin , M. Balzarin , N. Riera , P. Robinson , M. Haag , N. Moore , M.C. Sturkenboom , A. Pariente (Bordeaux, Padova, Barcelona, Rotterdam) |
| P-13/36 | NSAIDs safety evaluation: what
misses from RCTs? Methodological issues and knowledge gaps identified through
the SOS project F. Salvo, A. Fourrier-Réglat, F. Bazin , M. Balzarin , N. Riera, M. Haag , N. Moore , M.C. Sturkenboom , A. Pariente (Bordeaux, Padova, Barcelona, Rotterdam) |
| P-13/37 | Pattern of triptan use and cardiovascular co-prescription: a
pharmacoepidemiological study in Italy C. Biagi, E. Poluzzi, G. Roberto, A. Puccini, A. Vaccheri, R. D'Alessandro, D. Motola, N. Montanaro (Bologna) |
| P-13/38 | Predictors of non-adherence with oral bisphosphonates: an Italian
retrospective cohort study on administrative databases C. Piccinni, A. Puccini, C. Suzzi, E. Poluzzi, C. Sacripanti, E. Buccellato, F. Lapi, G. Mazzaglia, A. Vaccheri (Bologna, Firenze) |
| P-13/39 | Prescription
patterns of oral bisphosphonates in Italian patients with osteoporosis C. Suzzi, C. Piccinni, A. Puccini, E. Poluzzi , C. Sacripanti, E. Buccellato, F. Lapi, G. Mazzaglia, A. Vaccheri (Bologna, Firenze) |
| P-13/40 | Risk of potentially drug-induced
hepatic injury in paediatric population: data mining on electronic healthcare
databases in Europe C. Ferrajolo, KMC. Verhamme, A. Capuano, G. Trifirò, A. Oteri, G. Picelli, G. Mazzaglia, C. Cricelli, F. Rossi, MCJM. Sturkenboom (Napoli, Rotterdam, Messina, Desio, Firenze) |
| P-13/41 | Antiepileptic drugs: prescribing
patterns and interaction risk in general practice. M.S. Gagliostro, R. Ferrara, C. Sirianni, C. Pagliaro, I. Lombardi, S. Moretti, M. Tari, A. Capuano, E. Spina, V. Arcoraci (Messina, Caserta, Napoli) |
| P-13/42 | Risk-management of natalizumab: a
drug utilization study on duration of therapy and cause of discontinuation in
Emilia-Romagna region. C. Sacripanti, C. Piccinni, A. Puccini, E. Poluzzi, N. Montanaro (Bologna) |
| P-13/43 | Development and validation of
“CeNSE”: a score to Classify paiN and palliative care SErvices. E. Lucenteforte, V. Maggini, S. Rodella, F. Collini, G. Guidi, M. Scollo Abeti, A. Messeri, A. Mugelli, F. Lapi, A. Vannacci (Firenze) |
| P-13/44 | “Fiesole
Misurata” database: an ongoing project to investigate how to enhance
adherence to antihypertensive medications E. Lucenteforte, R. Bonaiuti, V. Maggini, A. Pugi, M. Moschini, M. Di Pirro, A. Barchielli, M. Belladonna, N. Nesti, A. Ungar, A. Mugelli, A. Vannacci, F. Lapi (Firenze) |
| P-13/45 | Use of Proton Pump Inhibitors (PPIs) in clinical practice: a
population-based study in the years 2004-2009 C. Sirianni, R. Ferrara, M.S. Gagliostro, A. Cannata, C. Pagliaro, I. Lombardi, S. Moretti, M. Tari, A. Capuano, F. Rossi, A.P. Caputi, V. Arcoraci (Messina, Caserta, Napoli) |
| P-13/46 | ACE inhibitors and
Angiotensin
II Receptor Blockers (ARBs) prescribing patterns: 6 years follow-up in
general practice R. Ferrara, C. Sirianni, M.S. Gagliostro, A. Cannata, C. Pagliaro, I. Lombardi, S. Moretti, M. Tari, A. Capuano, F. Rossi, A.P. Caputi, V. Arcoraci (Messina, Caserta, Napoli) |
| P-13/47 | Low Molecular Weight
Heparinsprescribing patterns in the Local Health Authority of Messina, Italy,
during 2010 S. Coppolino, C. Sgroi ( Messina) |